Novartis Investigative Site

Ciudad Aut6noma de Buenos Aires, Buenos Aires C1050AAK

0 studies enrolling now · 2 studies all time

What they study most

Cancer, Neoplasms, Gastrointestinal Tract, Renal Cell Carcinoma (RCC)

Studies at this site

• LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib — Completed
• A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC) — Completed